42.12 +1.53 (3.77%)
Pre-Market: 7:18AM EDT
|Bid||42.09 x 3900|
|Ask||42.11 x 200|
|Day's Range||40.23 - 40.60|
|52 Week Range||34.14 - 42.35|
|PE Ratio (TTM)||18.84|
|Forward Dividend & Yield||0.99 (2.51%)|
|1y Target Est||46.80|
Philips (PHG.AS) is worried about rising trade tensions between the United States and China, said the Dutch health-technology company that is banking on continuing Chinese demand for its high-end medical equipment. Strong demand from Chinese hospitals for its ultrasound machines, medical scanners and other equipment helped Philips' first-quarter results beat analyst expectations on Monday, but the simmering trade dispute between the United States and China could threaten future earnings. "So far the effects are modest, but we are worried about the trade tensions," Chief Executive Frans van Houten told Reuters in a telephone interview.
Philips is worried about rising trade tensions between the United States and China, said the Dutch health-technology company that is banking on continuing Chinese demand for its high-end medical equipment. Strong demand from Chinese hospitals for its ultrasound machines, medical scanners and other equipment helped Philips' first-quarter results beat analyst expectations on Monday, but the simmering trade dispute between the United States and China could threaten future earnings.
AMSTERDAM (Reuters) - Dutch health technology company Philips (PHG.AS) on Monday said rising trade tensions between the United States and China are having a negative effect on its results, as they drive ...
Dutch health technology company Philips' first-quarter results beat expectations on Monday, as customers in China and the United States increased their demand for its high-end hospital equipment. Core profit in the first three months of the year rose 15 percent to 344 million euros ($422.1 million), Philips said, on a comparable sales growth of 5 percent and a 10 percent increase in new orders. "While there is more work to be done, 2018 started well," Chief Executive Frans van Houten said in a statement, reaffirming the company's target of a 4-6 percent sales growth for the year.
Royal Philips NV Chief Executive Officer Frans van Houten said the Dutch manufacturer of medical equipment remains on the hunt for companies to buy as it hones focus on the health-care sector. “We are interested to do bolt-on acquisitions,” he said in an interview on Monday with Bloomberg TV after publishing quarterly earnings. The company based in Amsterdam reported 10 percent growth in comparable order intake, reflecting a series of multi year contracts to provide imaging services to hospitals including in the U.K. and Canada.
Dutch health technology company Philips said on Monday its first quarter core profit rose 15 percent to 344 million euros , on increased demand from customers in China and the United States for its high-end ...
The oft-criticized name, merging the words “health” and “engineers,” actually belongs to a unit of German industrial conglomerate Siemens (ticker:ticker::SIE.Germany) that had a successful trading debut last month. While shares in Siemens Healthineers (SHL.Germany) have danced higher so far, investors might not want to bet that big gains will continue. Analysts say Royal Philips (PHIA.Netherlands) looks like the best competitor to compare Healthineers against.
Collaboration with Sun Nuclear helps improve the quality, consistency and efficiency of radiation oncology treatment planning AMSTERDAM and BARCELONA, Spain , April 19, 2018 /PRNewswire/ -- Royal Philips ...
BETHLEHEM, Pa., April 16, 2018-- B. Braun Medical Inc. will introduce its first FDA-approved local anesthetic for spinal anesthesia-- Clorotekal ®-- at the American Society of Regional Anesthesia and Acute ...
On March 2, 2018, Hologic (HOLX) announced a global partnership with Royal Philips (PHG) to provide an integrated health solution for women comprised of diagnostic imaging modalities and advanced informatics along with screening, diagnosis, and treatment services. According to the agreement, some of the selected products from Hologic’s breast health portfolio will be available for Royal Philips to offer as part of its multi-modality deals for healthcare providers, hospitals, and more. The selected products include Hologic’s breast screening technologies, interventional radiology technologies, and its 3Dimensions Mammography System, the fastest breast tomosynthesis system in the market.
The latest earnings announcement Koninklijke Philips NV.’s (ENXTAM:PHIA) released in December 2017 showed that the company benefited from a slight tailwind, leading to a single-digit earnings growth of 3.30%. BelowRead More...
LAS VEGAS, March 27, 2018 /PRNewswire/ -- Today at Medtrade Spring in Las Vegas, Nevada (March 27-29), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of DreamWear Full face, the third mask option available for its award-winning DreamWear mask system. Philips Respironics, the number one choice brand of U.S. sleep physicians for continuous positive airway pressure (CPAP) and masks, used the company's proprietary design tools to analyze facial data from thousands of 3D scans to create a design that prevents red marks, discomfort, and irritation on the nose bridge.
NEW YORK, March 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Industry-first integrated tele-ultrasound solution breaks down barriers for care providers – from clinicians, teaching institutions, medical students and residents to EMS personnel, disaster relief organizations ...
- Industry-first integrated tele-ultrasound solution breaks down barriers for care providers - from clinicians, teaching institutions, medical students and residents to EMS personnel, disaster relief organizations ...
Philips enhances point-of-care ultrasound with Reacts platform for remote collaboration and virtual training
Philips provides University of Ottawa Heart Institute with innovative health technology solutions for their expanded cardiovascular care facility
Philips delivers patient monitoring, cardiac ultrasound and image guided therapy solutions to Canada's largest heart health centre. This new expansion will contain all life support services, including operating rooms, interventional suites and a Cardiac Surgery intensive care unit, providing greater capacity and efficiencies and will support the advanced and rapidly changing technologies required to care for patients with the most complex medical needs.
AMSTERDAM, March 19, 2018 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), both members of the Partners HealthCare network, will implement the Philips IntelliSite Pathology Solution  to enable research and support clinical diagnosis. Leveraging Philips' comprehensive portfolio of advanced digital pathology solutions, MGH and BWH aim to deploy digital pathology infrastructures to enable digital pathology research, education and collaboration and to help shape and inform the deployment of digital pathology across the country by establishing best practices and protocols.
Koninklijke Philips's (PHG) new Digital Radiography-Fluoroscopy system receives approval of the U.S. Food and Drug Administration for marketing.
Two-in-one Digital Radiography-Fluoroscopy system provides low-dose, high-quality images while supporting fast workflow, broadening clinical capacity and increasing room utilization AMSTERDAM , March 15, ...
Newly released artificial intelligence (AI)-driven TissueMark software empowers research labs to enhance quality and reliability, and reduce costs AMSTERDAM and VANCOUVER, British Columbia , March 15, ...
Koninklijke Philips NV. (ENXTAM:PHIA) is trading with a trailing P/E of 36x, which is higher than the industry average of 33.4x. Although some investors may jump to the conclusion thatRead More...